Zalgen Labs LLC, a biotechnology and diagnostics company focused on high-impact, neglected infectious diseases, announced that it has entered into a series of agreements with Springdale-headquartered company NOWDiagnostics Inc. (NOWDx) to collaborate in the development, manufacturing and commercialization of infectious disease diagnostic products. Under the terms of the agreements, the parties will collaborate in bringing new rapid infectious disease tests to the global market.
Zalgen is a partner of the Viral Hemorrhagic Fever Consortium, an academic and industry partnership lead by Tulane University, developing state-of-the-art diagnostic and immunotherapeutic products for biothreat agents and emerging pathogens.
